One shot gene therapy could free patients from monthly eye injections
NCT ID NCT05930561
Summary
This study is testing a one-time gene therapy injection (called 4D-150) for adults with diabetic macular edema, a condition that causes swelling and vision loss. The goal is to see if this single treatment can safely reduce the need for the frequent eye injections patients currently require. Researchers will compare the gene therapy against the standard treatment over two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Clinical Research
Austin, Texas, 78750, United States
-
Cumberland Valley Retina Consultants
Hagerstown, Maryland, 21740, United States
-
Emanuelli Research and Development Center
Arecibo, X00612, Puerto Rico
-
Erie Retina Research
Erie, Pennsylvania, 16507, United States
-
Piedmont Eye Center
Lynchburg, Virginia, 24502, United States
-
Verum Research, LLC
Eugene, Oregon, 97401, United States
Conditions
Explore the condition pages connected to this study.